Beta-Amyloid 42/40 Ratio
Synonyms |
|
||||||||||||||||
Cerner Name |
|||||||||||||||||
Clinical Info |
This LC-MS/MS assay measures beta-amyloid 40 (AB40) as well as AB42 in plasma, rather than AB42 alone. This permits the normalization of beta amyloid levels circulating in plasma in different patients. Using the ratio of beta-amyloid 42/beta-amyloid 40, improves sensitivity and specificity for detecting Alzheimer's disease. |
||||||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||||||
Specimen Types |
Blood |
||||||||||||||||
Specimen Volume |
1.2 mL plasma (0.6 mL min) |
||||||||||||||||
Container |
Lavender Top Tube |
||||||||||||||||
Collection Instructions |
Container/Tube: Lavender Top Tube |
||||||||||||||||
Transport Instructions |
Frozen |
||||||||||||||||
Specimen Stability |
Unacceptable Room Temperature |
||||||||||||||||
Methodology |
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) |
||||||||||||||||
Days Performed |
TAT: 5-7 Days |
||||||||||||||||
Performing Laboratory |
Quest Diagnostics Nichols Institute San Juan Capistrano CA |
||||||||||||||||
CPT |
82233 |
||||||||||||||||
PDM |
245767 |
||||||||||||||||
Only Orderable at Locations: |
Orderable Everywhere |
||||||||||||||||
Results |
|
||||||||||||||||
Result Interpretation
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. |
|||||||||||||||||
Forms |
|